Health Ministry Confirms Breakthrough Case
French health authorities have confirmed the first detection of cereulide toxin in a baby who was hospitalized after consuming a recalled infant formula product. The Ministry of Health announced on Friday that it received a “first positive stool analysis result for cereulide toxin” from the infant. The Directorate General for Health stated this confirms the child was exposed to the toxin, which could explain the observed symptoms, but emphasized it does not yet establish a definitive causal link.
Global Recall Wave Intensifies
The infant formula crisis began in December with Nestlé’s recall of dozens of batches across approximately sixty countries due to potential cereulide contamination. This toxin can cause dangerous vomiting in newborns. Since then, a cascade of similar recalls has followed globally, involving major manufacturers like Danone and Lactalis, as well as smaller players in the growing market.
France is the only European country to report fatalities in connection with the recalled products, with three deaths and about ten hospitalizations noted. However, authorities have previously cautioned that establishing a direct causal link is challenging. This first confirmed presence of the toxin in a French infant who consumed a recalled product marks a significant development and a potential indicator of poisoning.
Case Details and International Context
The ministry did not disclose specific case details. According to Radio France, the infant was hospitalized for one night in early February in Montpellier after consuming Gallia brand formula, which is produced by Danone.
Internationally, the presence of cereulide was reported about ten days ago in Belgium in eight infants, all of whom exhibited only mild symptoms. Belgium serves as the central hub for analyses in this case. France, lacking a domestic laboratory authorized to detect the toxin at identified risk thresholds, sends samples from French infants to the Belgian public health laboratory for testing.
Ongoing Investigations and Expert Assessment
While acknowledging the toxin’s presence could explain the symptoms, the Health Ministry refrained from declaring definitive “imputability.” It stated that determining causality “belongs to the competent experts, notably the caregivers who treated the child and the toxicology specialists mobilized as part of the investigations.”
This development adds a critical piece of evidence as health officials and manufacturers worldwide continue to grapple with the safety and supply chain implications of the widespread infant formula recalls.
